The Newsroom
Research·October 23, 2026 at 12:00 AM EDT·1 source

China’s rapid human trials draw western drugmakers — and safety concerns

AZN -0.6%
AZN · last 30 trading days+1.8% since the news
News

What happened

  • Pharma groups including AstraZeneca are using China’s fast-track route for human trials of cutting-edge medicines.
  • The rapid testing approach is attracting Western drugmakers while raising safety concerns.

Why it matters

The approach could affect drug-development timelines and clinical-testing strategies for healthcare companies and their advisers, while safety concerns may influence transaction and investment decisions.

Read more on YouBank

The Newsroom, ranked for your desk

About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.

Timeline

  1. EarlierOct 20
    AstraZeneca Partners With Oracle to Refine Clinical Research With AI
  2. EarlierOct 22
    Roche talks up Phase 3 success rate as it unveils pipeline cuts
  3. First reported by Financial TimesOct 23
    China’s rapid human trials draw western drugmakers — and safety concerns

Sources (1)

  1. Financial TimesOct 23
    China’s rapid human trials draw western drugmakers — and safety concerns

Related

Read more on YouBank

The Newsroom, ranked for your desk

About ninety free sources every ten minutes, one story per event, read for you: bankers, investors, operators and students each get their own desk. Free to start.

  • Why it matters to youEvery story matched to your watchlist, your contacts and your pipeline.
  • Follow developing storiesAn alert, and a push, the moment a story you follow moves.
  • Your briefing, read aloudA few minutes each morning with a chapter per story.
  • Brief modeSwipe through the day, a 20-second card each.